Published in J Ophthalmic Inflamm Infect on March 16, 2011
Multifocal choroiditis and panuveitis. A syndrome that mimics ocular histoplasmosis. Arch Ophthalmol (1984) 1.72
Epstein-Barr viral antibodies in multifocal choroiditis and panuveitis. Am J Ophthalmol (1987) 1.53
Multifocal choroiditis with panuveitis and punctate inner choroidopathy: comparison of clinical characteristics at presentation. Retina (2007) 1.34
Fundus autofluorescence in multifocal choroiditis and panuveitis. Am J Ophthalmol (2008) 1.30
Multifocal choroiditis and panuveitis: immunomodulatory therapy. Ophthalmology (2002) 1.20
Investigation of multifocal choroiditis with panuveitis by three-dimensional high-penetration optical coherence tomography. J Biophotonics (2009) 1.09
Diagnosis of acute pulmonary histoplasmosis by antigen detection. Clin Infect Dis (2009) 1.09
Comparison of an established antibody sandwich method with an inhibition method of Histoplasma capsulatum antigen detection. J Clin Microbiol (2000) 0.91
Inflammatory pseudohistoplasmosis. Ann Ophthalmol (1985) 0.90
Differentiation between presumed ocular histoplasmosis syndrome and multifocal choroiditis with panuveitis based on morphology of photographed fundus lesions and fluorescein angiography. Arch Ophthalmol (2001) 0.88
Presumed ocular histoplasmosis. II. Patterns of peripheral and peripapillary scarring in persons with nonmacular disease. Arch Ophthalmol (1972) 0.83
Blind spot enlargement as a manifestation of multifocal choroiditis. Arch Ophthalmol (1991) 0.81
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology (2012) 8.29
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology (2006) 5.79
Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA (2003) 5.33
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med (2010) 4.95
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology (2010) 3.49
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology (2013) 2.99
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study. Ophthalmology (2009) 2.77
Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther (2008) 2.59
Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther (2006) 2.59
Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol (2006) 2.50
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology (2013) 2.43
New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res (2006) 2.35
Evaluation of patients with scleritis for systemic disease. Ophthalmology (2004) 2.22
One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology (2012) 2.20
Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol (2009) 2.02
Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants. Ophthalmology (2012) 1.95
Retinal thickness analysis by race, gender, and age using Stratus OCT. Am J Ophthalmol (2009) 1.86
Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study. J Ophthalmic Inflamm Infect (2013) 1.85
Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology (2005) 1.80
Recent trends in the management of rhegmatogenous retinal detachment. Surv Ophthalmol (2008) 1.78
Endothelial dystrophy, iris hypoplasia, congenital cataract, and stromal thinning (edict) syndrome maps to chromosome 15q22.1-q25.3. Am J Ophthalmol (2002) 1.56
Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment. JAMA Ophthalmol (2013) 1.55
Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration. Retina (2010) 1.54
Encephalitis and myelitis associated with dengue viral infection clinical and neuroimaging features. Clin Neurol Neurosurg (2008) 1.53
Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology (2005) 1.46
PharmD in Pakistan: a tag or a degree? Am J Pharm Educ (2009) 1.46
Comparison of time- and spectral-domain optical coherence tomography in management of diabetic macular edema. Invest Ophthalmol Vis Sci (2014) 1.45
Persistent diabetic macular edema is associated with elevated hemoglobin A1c. Am J Ophthalmol (2005) 1.43
Blood pressure control for diabetic retinopathy. Sao Paulo Med J (2015) 1.40
New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence. Acta Ophthalmol Scand (2007) 1.40
Helicobacter pylori infection and duodenal gastric metaplasia in healthy young adults. Korean J Gastroenterol (2013) 1.38
Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology (2007) 1.36
The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing. Ophthalmology (2011) 1.34
RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027. Am J Ophthalmol (2010) 1.27
Progression of macular ischemia following intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging (2009) 1.25
DNA damage in oocytes induces a switch of the quality control factor TAp63α from dimer to tetramer. Cell (2011) 1.25
A phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degeneration. Ophthalmology (2006) 1.23
Supplemental oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci (2004) 1.20
Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degeneration. Ophthalmology (2011) 1.18
Use of retinal procedures in medicare beneficiaries from 1997 to 2007. Arch Ophthalmol (2010) 1.14
Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes. Ophthalmology (2010) 1.13
Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer. J Vasc Interv Radiol (2007) 1.13
A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration. Ophthalmology (2009) 1.13
Monitoring ocular drug therapy by analysis of aqueous samples. Ophthalmology (2009) 1.12
CHRK1, a chitinase-related receptor-like kinase, interacts with NtPUB4, an armadillo repeat protein, in tobacco. Biochim Biophys Acta (2003) 1.12
Wide-field retinal imaging in the management of noninfectious posterior uveitis. Am J Ophthalmol (2012) 1.08
Hospitalized cardiovascular diseases in neovascular age-related macular degeneration. Arch Ophthalmol (2008) 1.07
Characterization of macular lesions in punctate inner choroidopathy with spectral domain optical coherence tomography. J Ophthalmic Inflamm Infect (2012) 1.07
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert. Ophthalmology (2010) 1.06
Early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity. Middle East Afr J Ophthalmol (2010) 1.03
Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study. J Pharmacol Exp Ther (2008) 1.02
Measurement of oxygen saturation in the retina with a spectroscopic sensitive multi aperture camera. Opt Express (2008) 1.02
Retinal optical coherence tomography manifestations of intraocular lymphoma. J Ophthalmic Inflamm Infect (2012) 1.01
Changing patterns and outcome of Dengue infection; report from a tertiary care hospital in Pakistan. J Pak Med Assoc (2008) 1.01
Management of retained subretinal perfluorocarbon liquid. Ophthalmic Surg Lasers Imaging Retina (2013) 0.99
Breast cancer in malaysia: are our women getting the right message? 10 year-experience in a single institution in Malaysia. Asian Pac J Cancer Prev (2007) 0.99
Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies. Am J Ophthalmol (2009) 0.98
Prohibitin is involved in mitochondrial biogenesis in plants. Plant J (2006) 0.97
Retina-simulating phantom for optical coherence tomography. J Biomed Opt (2014) 0.97
A cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States. Ophthalmology (2010) 0.97
Dynamic and quantitative analysis of choroidal neovascularization by fluorescein angiography. Invest Ophthalmol Vis Sci (2006) 0.96
Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy. Ocul Immunol Inflamm (2011) 0.96
Impact of optical coherence tomography on surgical decision making for epiretinal membranes and vitreomacular traction. Retina (2007) 0.96
Absolute blood velocity measured with a modified fundus camera. J Biomed Opt (2010) 0.96